HELICOS BIOSCIENCES CORP (HLCS) [Rocket]

In millions, except per share items	Dec-31-11	Dec-31-10	May-09-10	Dec-31-09	Dec-31-08	Dec-31-07	May-09-07	Dec-31-06
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Service revenue	1.2
Product revenue	0.6	1.3		2.3
Other	1.5	3.1		0.7
Total revenues [+]	3.2	4.4	9.0	3.0	0.8	0.6		0.2
Royalties	4.9	14.0		18.3
Products	0.6	1.3		2.3
Services	1.2
Revenue growth [+]	-26.5%	45.3%		274.5%	38.8%	266.0%
Product revenue	-56.1%	-44.0%
Cost of goods sold	0.2	0.7	2.0	1.2	0.0	0.0		0.0
Gross profit	3.0	3.7	7.0	1.8	0.8	0.6		0.2
Gross margin	93.1%	83.8%	78.1%	59.1%	98.8%	100.0%		100.0%
Selling, general and administrative	4.1	10.5	70.9	12.5	20.1	14.3		6.9
Research and development		14.0		18.3		24.8		14.4
Other operating expenses	4.9		108.7		24.6
EBITDA [+]		-19.9		-26.6
EBITDA growth	-69.5%	-25.5%		-39.4%
EBITDA margin	-187.2%	-451.4%	-1923.7%	-880.4%	-5440.1%
Depreciation and amortization		1.0		2.3
EBIT [+]	-6.0	-20.9	-172.6	-29.0	-44.0	-38.5		-21.1
EBIT growth	-71.0%	-27.9%		-34.1%	14.2%	82.1%		87.4%
EBIT margin	-187.2%	-474.6%	-1923.7%	-956.7%	-5440.1%	-6613.1%		-13295.6%
Non-recurring items [+]		1.9	1.9
Asset impairment		1.9	1.9
Interest expense, net [+]	0.7	0.6	0.4	1.0	1.7	-1.7		-0.6
Interest expense	0.7	0.6	4.5	1.0	2.4	0.3		0.2
Interest income		0.0	4.2	0.1	0.7	2.0		0.8
Other income (expense), net	0.9	4.6	6.5	2.0		-18.1
Pre-tax income	-5.8	-18.8	-168.3	-28.0	-45.7	-54.9		-20.6
Income taxes	0.0	0.0	0.0	0.0	0.0	-18.1		0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	33.0%		0.0%
Net income	0.0	-18.8	-168.3	-28.0	0.0	-54.9		-20.6
Net margin	-0.2%	-426.8%	-1875.8%	-924.0%	-5.6%	-9440.7%		-12943.4%

Basic EPS [+]	($0.07)	($0.24)	($186,433.00)	($0.42)	($2.10)	($4.23)		($16.35)
Growth	-72.0%	-43.7%		-79.7%	-50.4%	-74.1%		29.6%
Diluted EPS [+]	($0.07)	($0.24)	($186,433.00)	($0.42)	($2.10)	($4.23)		($16.35)
Growth	-72.0%	-43.7%		-79.7%	-50.4%	-74.1%		29.6%

Shares outstanding (basic) [+]	0.1	78.4	0.0	65.8	0.0	13.0		1.3
Growth	-99.9%	19.1%		302256.4%	-99.8%	932.2%		45.4%
Shares outstanding (diluted) [+]	0.1	78.4	0.0	65.8	0.0	13.0		1.3
Growth	-99.9%	19.1%		302256.4%	-99.8%	932.2%		45.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.